Clinical Study of Chidamide Combined With Fulvestrant in the Treatment of Hormone Receptor-positive Advanced Breast Cancer
Clinical trial NCT05047848 · UNKNOWN
Trial details
- NCT number
- NCT05047848
- Sponsor
- Liaoning Cancer Hospital & Institute
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-18
- Primary completion
- 2022-06-18
- Enrollment
- 82
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.